Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people

[1]  E. Fabian,et al.  Age‐related modification of antioxidant enzyme activities in relation to cardiovascular risk factors , 2012, European journal of clinical investigation.

[2]  J. Loscalzo,et al.  Oxidative risk for atherothrombotic cardiovascular disease. , 2009, Free radical biology & medicine.

[3]  Richard Kahn,et al.  The impact of prevention on reducing the burden of cardiovascular disease. , 2008, Circulation.

[4]  Richard Kahn,et al.  The Impact of Prevention on Reducing the Burden of Cardiovascular Disease , 2008, Diabetes Care.

[5]  Maristela L Onozato,et al.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.

[6]  V. Ganji,et al.  Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. , 2006, The American journal of clinical nutrition.

[7]  Xiao-hong Zhang,et al.  Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. , 2006, Vascular pharmacology.

[8]  R. Castro,et al.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview , 2006, Journal of Inherited Metabolic Disease.

[9]  S. Tyagi,et al.  Mechanisms of homocysteine-induced oxidative stress. , 2005, American journal of physiology. Heart and circulatory physiology.

[10]  J. Leiper,et al.  The DDAH-ADMA-NOS Pathway , 2005, Therapeutic drug monitoring.

[11]  T. Teerlink.  ADMA metabolism and clearance , 2005 .

[12]  S. Morris.  Arginine metabolism in vascular biology and disease , 2005, Vascular medicine.

[13]  T. Teerlink.  ADMA metabolism and clearance , 2005, Vascular medicine.

[14]  S. Morris.  Arginine metabolism in vascular biology and disease , 2005 .

[15]  J. Boucher,et al.  Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. , 2004, Free radical biology & medicine.

[16]  C. L. Peng,et al.  Plasma homocysteine reference values of adult Malaysians from three ethnic groups. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[17]  P. Vallance,et al.  The DDAH/ADMA/NOS pathway. , 2003, Atherosclerosis. Supplements.

[18]  M. Weger,et al.  DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations , 2003, Clinical chemistry and laboratory medicine.

[19]  C. Yen,et al.  Homocysteine altered ROS generation and NO accumulation in endothelial cells. , 2003, The Chinese journal of physiology.

[20]  A. Wardlaw,et al.  Expression of and functional responses to protease‐activated receptors on human eosinophils , 2003, Journal of leukocyte biology.

[21]  H. Blom,et al.  Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease , 2002, Pharmacological Reviews.

[22]  I. Mcdowell,et al.  Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us? , 2002, Atherosclerosis.

[23]  R. Holman,et al.  Underestimation of the Importance of Homocysteine as a Risk Factor for Cardiovascular Disease in Epidemiological Studies , 2001, Journal of cardiovascular risk.

[24]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[25]  P. Tsao,et al.  Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine , 2001, Circulation.

[26]  R. B. Caldwell,et al.  Endothelial cell dysfunction in a model of oxidative stress. , 2001, Medical science monitor : international medical journal of experimental and clinical research.

[27]  J. Strong,et al.  Origin of atherosclerosis in childhood and adolescence. , 2000, The American journal of clinical nutrition.

[28]  M. Goligorsky,et al.  Effects of homocysteine on endothelial nitric oxide production. , 2000, American journal of physiology. Renal physiology.

[29]  M. McKinley,et al.  Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease , 2000, Proceedings of the Nutrition Society.

[30]  S. Kittner,et al.  Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Examination Survey. , 2000, American heart journal.

[31]  H. Philippou,et al.  Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. , 2000, Circulation.

[32]  S. Ebrahim,et al.  Serum total homocysteine and coronary heart disease: prospective study in middle aged men , 1999, Heart.

[33]  I. Graham.  Homocysteine in Health and Disease , 1999, Annals of Internal Medicine.

[34]  S. Yusuf,et al.  Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence , 1999, Annals of Internal Medicine.

[35]  I. Rosenberg,et al.  Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (19911994): Population Reference Ranges and Contribution of Vitamin Status to High Serum Concentrations , 1999, Annals of Internal Medicine.

[36]  P. Vallance,et al.  Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. , 1999, Cardiovascular research.

[37]  R. Krauss,et al.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.

[38]  R. Newcombe,et al.  Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. , 1998, Circulation.

[39]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[40]  K. Rasmussen,et al.  Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. , 1996, Clinical chemistry.

[41]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[42]  S. Moncada,et al.  Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis , 1992, Journal of cardiovascular pharmacology.

[43]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[44]  J. Ubbink,et al.  Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. , 1991, Journal of chromatography.

[45]  G. A. Rose,et al.  A simple liquid-chromatographic method for measuring vitamin B6 compounds in plasma. , 1989, Clinical chemistry.

[46]  P. Mumford,et al.  Nutrient intake. , 1979, British medical journal.

[47]  N. Murthy.  Laboratory Tests for the Assessment of Nutritional Status , 1976 .

[48]  D. Kaye,et al.  Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation. , 2008, The international journal of biochemistry & cell biology.

[49]  A. Smith,et al.  Facts and recommendations about total homocysteine determinations: an expert opinion. , 2004, Clinical chemistry.

[50]  D. Tsikas,et al.  ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. , 2003, Cardiovascular research.

[51]  S. Vollset,et al.  Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project. , 2003, The American journal of clinical nutrition.

[52]  S. Bode-Böger,et al.  Asymmetric Dimethylarginine, Derangements of the Endothelial Nitric Oxide Synthase Pathway, and Cardiovascular Diseases , 2000, Seminars in thrombosis and hemostasis.

[53]  R. Wolfe,et al.  Homocysteine metabolism. , 1999, Annual review of nutrition.

[54]  J. H. Skala,et al.  Laboratory tests for the assessment of nutritional status. , 1973, CRC critical reviews in clinical laboratory sciences.